Ubiquitin linkage to cysteine is an unconventional modification targeting protein for degradation. However, the physiological regulation of cysteine ubiquitylation is still mysterious. Here we found that ACAT2, a cellular enzyme converting cholesterol and fatty acid to cholesteryl esters, was ubiquitylated on Cys277 for degradation when the lipid level was low. gp78-Insigs catalysed Lys48-linked polyubiquitylation on this Cys277. A high concentration of cholesterol and fatty acid, however, induced cellular reactive oxygen species (ROS) that oxidized Cys277, resulting in ACAT2 stabilization and subsequently elevated cholesteryl esters. Furthermore, ACAT2 knockout mice were more susceptible to high-fat diet-associated insulin resistance. By contrast, expression of a constitutively stable form of ACAT2 (C277A) resulted in higher insulin sensitivity. Together, these data indicate that lipid-induced stabilization of ACAT2 ameliorates lipotoxicity from excessive cholesterol and fatty acid. This unconventional cysteine ubiquitylation of ACAT2 constitutes an important mechanism for sensing lipid-overload-induced ROS and fine-tuning lipid homeostasis.
The ubiquitin-proteasome pathway plays a vital role in regulating protein homeostasis. Ubiquitin is often linked to lysine residues and less frequently to the amino terminus of proteins via an amide bond. Some viral E3s can also attach ubiquitin to the SH moiety of cysteine residues through a thioester bond 1 . This unconventional ubiquitin linkage similarly targets modified proteins, such as myosin heavy chain I, for proteasomal degradation. However, little is known about the physiological significance of a cysteine residue being a ubiquitylation site.
Cholesterol and fatty acid (FA) are essential lipids involved in many biological processes. However, excessive polar lipids, such as free cholesterol (FC) and free FA (FFA), are the major risk factors for atherosclerosis and type 2 diabetes mellitus. One of the mechanisms by which lipid overload causes lipotoxicity and insulin resistance is the generation of reactive oxygen species (ROS) 2 . Cholesterol and oxysterols can cause mitochondria dysfunction and ROS production 3, 4 . Saturated FAs, but not unsaturated FAs, also efficiently induce ROS generation through activating NADPH oxidation and mitochondrial electron transport 5, 6 . However, how cells sense and adapt to lipid-overload-induced oxidative stress remains elusive.
Acyl-CoA:cholesterol acyltransferase (ACAT) (EC 2.3.1.26, also known as sterol O-acyltransferase (SOAT)) is an endoplasmic reticulum (ER)-membrane-spanning enzyme converting cholesterol and FA to cholesteryl esters (CEs) 7 . There are two ACATs. ACAT1 is ubiquitously expressed and regulates cholesterol homeostasis, whereas ACAT2 is selectively expressed in the small intestine and liver for efficient dietary cholesterol absorption and lipoprotein assembly [8] [9] [10] . Both ACATs can convert toxic polar lipids to less toxic neutral lipids. The enzymatic activity of ACATs is highly activated by cholesterol through an allosteric mechanism 11 . However, the regulation of ACAT protein amount is poorly understood.
Here, we show that ACAT2 is ubiquitylated on Cys277 when the cellular lipid level is low. High levels of cholesterol and FA induce ROS, which oxidize Cys277 and prevent ACAT2 ubiquitylation and degradation. Moreover, ACAT2 knockout (ACAT2 −/− ) mice are more susceptible to high-fat diet (HFD)-induced insulin resistance. Re-expressing a constitutively stable form of ACAT2 (C277A) in the liver of ACAT2 −/− mice increases insulin sensitivity. From these results we conclude that ROS-mediated stabilization of ACAT2 provides a critical mechanism for fine-tuning lipid overload. Figure 1 ACAT2 is stabilized by sterols and saturated fatty acids. (a,b) Cells (HepG2, Huh7, Hepa1-6 and Caco2) were depleted of lipids by incubating in medium supplemented with 5% lipoprotein-deficient serum, 1 µM lovastatin and 50 µM mevalonate for 16 h. Then the cells were treated without (−) or with (+) sterols (15 µg ml −1 cholesterol and 3 µg ml −1 25-HC) for 16 h. The cells were harvested for western blotting and RT-qPCR (n = 3 independent experiments, mean ± s.d.). (c,d) Male C57/BL6 mice (8-12 weeks) were fed on chow diet or high-cholesterol diet (chow diet supplemented with 2% cholesterol) for 24 and 48 h. The liver and small intestine samples were subjected to western blotting and RT-qPCR analysis (mean ± s.d., n = 5 mice). (e-g) The CHO/ACAT2-Myc cells were depleted of lipids as in Fig. 1a . Then the cells were treated with different sterols (e), FAs (f) and cholesterol together with FAs (g) at the indicated concentrations. After incubation for 16 h, the cells were harvested for western blotting. The immunoblots are representative of at least three independent experiments. Unprocessed original scans of blots are shown in Supplementary Fig. 8 . Statistics source data for b,d can be found in Supplementary Table 2 .
RESULTS

ACAT2 is stabilized by sterols and saturated fatty acids
We first examined whether endogenous ACATs respond to sterol stimulation. The protein level of ACAT2 but not ACAT1 dramatically increased following cholesterol and 25-hydroxycholesterol (25-HC) treatments in various cells (Fig. 1a ). Notably, their messenger RNAs were unchanged (Fig. 1b ). In line with these in vitro findings, a high-cholesterol diet substantially increased ACAT2 protein but not mRNA in mouse liver and small intestine ( Fig. 1c,d) . We next determined the effects of various sterols on ACAT2 protein level. As shown in Supplementary Fig. 1 , sterol intermediates of cholesterol biosynthesis (desmosterol, 7-dehydrocholesterol (7-DHC), zymosterol and lanosterol), oxysterols and cholestanol markedly increased ACAT2 expression. However, ergosterol and phytosterols including β-sitosterol, stigmasterol and brassicasterol failed to elevate ACAT2 (Fig. 1e) . (a) CHO/ACAT2-Myc cells were depleted of lipids as depicted in Fig. 1a . The cells were then treated with 25-HC (3 µg ml −1 ) and PA (200 µM). Eight hours later, 10 µM MG132 or 20 mM NH 4 Cl was added. After an additional 8 h, cells were harvested for western blotting. (b) CHO/ACAT2-Myc cells were depleted of lipids and treated with 25-HC, PA or both as indicated. Eleven hours later, cells were treated with 10 µM MG132 for another 5 h. Cells were then harvested for ubiquitylation assay. (c) CHO cells were transfected with plasmids expressing ACAT2 variants and depleted of lipids. Cells were then treated with 25-HC for 16 h and subjected to western blotting. (d) CHO cells transfected with plasmids expressing ACAT2 variants were depleted of lipids and treated with 25-HC. Eleven hours later, cells were treated with MG132. After another 5 h, cells were harvested for ubiquitylation assay. (e) Schematic of the human ACAT2 protein. (f) CHO cells transfected with plasmids expressing the ACAT2 variants in e were depleted of lipids and treated with 25-HC.
Cells were harvested 16 h later for western blotting. (g) CHO cells transfected with plasmids expressing ACAT2 variants were depleted of lipids and treated with 25-HC. Eleven hours later, cells were treated with MG132. After another 5 h, cells were harvested for ubiquitylation assay. (h) CHO cells were transfected with plasmids expressing His 6 -and Myc-double-tagged ACAT2 variants together with haemagglutinin (HA)-tagged ubiquitin and depleted of lipids. Cells were then treated with MG132 for another 5 h. Cells were harvested and lysed in non-denaturing and denaturing immunoprecipitation (IP) buffers, and subsequently subjected to ubiquitylation assays. (i) CHO cells were transfected with the indicated plasmids, depleted of lipids and incubated with MG132 for 5 h. Cells were lysed in denaturing IP buffer, incubated with Ni-NTA beads and the precipitates were treated without (−) or with (+) BME (15 mg ml −1 ) followed by western blotting. The immunoblots are representative of three independent experiments. Unprocessed original scans of blots are shown in Supplementary Fig. 8 .
Given the fact that ACATs utilize both sterols and FAs as substrates, we next investigated the effects of FAs on ACATs. Palmitic acid (PA, 16:0), but not oleate acid (OA, 18:1), dramatically elevated the protein level of endogenous ACAT2 but not ACAT1 ( Supplementary Fig. 1c ). Neither ACAT1 nor ACAT2 mRNAs were altered ( Supplementary Fig. 1d ). Saturated FAs including PA, stearic acid (SA, 18:0) and arachidic acid (arachidic, 20:0) elevated ACAT2 in a dose-dependent manner (Fig. 1f ). However, unsaturated FAs such as OA (18:1), linoleic acid (LA, 18:2), α-linolenic acid (α-LA, 18:3), arachidonic acid (AA, 20:4) and docosahexaenoic acid (DHA, 22:6) exerted no effects on ACAT2 ( Fig. 1f ). Importantly, the ACAT2 protein level was synergistically increased by cholesterol and saturated FAs (Fig. 1g ).
Sterols and FAs prevent ACAT2 from ubiquitylation on Cys277
Figure 2a shows that inhibiting proteasome function by MG132 instead of lysosome function by NH 4 Cl blocked the lipid-stimulated increase of ACAT2. ACAT2 was ubiquitylated at the lipid-depleted condition, which was considerably reduced following treatment with 25-HC, PA or both ( Fig. 2b) . Ubiquitin is predominately conjugated to the lysine residues of target proteins. To determine whether certain lysine residues serve as the ubiquitylation sites, we constructed a mutant ACAT2 in which all seven lysine residues were replaced by arginines (indicated as K-null). Surprisingly, both wild-type (WT) and K-null forms of ACAT2 were ubiquitylated and underwent sterol-regulated stabilization ( Fig. 2c,d ), suggesting that the lysine residues are not responsible for ACAT2 ubiquitylation.
We next made a series of truncations to map the ubiquitylation site(s). The region spanning amino acids 252-279 is essential for sterol-regulated ACAT2 stabilization and may contain critical ubiquitylation site(s) ( Supplementary Fig. 2a-e ). Since ubiquitylation has also been shown to occur on serine, threonine or cysteine 1,12 , we substituted the serine, threonine or cysteine residues for alanine in the aforementioned region (amino acids 252-279) ( Fig. 2e ). The alanine replacement of either serine or threonine had no effect ( Fig. 2f ). However, C277A mutation significantly blocked ACAT2 degradation and ubiquitylation ( Fig. 2f,g) . Moreover, substituting other cysteine residues within a broader region (amino acids 227-328) barely affected ACAT2 stability ( Supplementary Fig. 2f -h). To exclude the possibility that ubiquitylation may take place on ACAT2-associated proteins, we pulled down WT and C277A forms of ACAT2 using anti-Myc beads in non-denaturing buffer or Ni-NTA beads in denaturing buffer. The ubiquitylation of WT but not mutant ACAT2 was detected in both conditions ( Fig. 2h ), suggesting that ACAT2 ubiquitylation indeed occurred on Cys277.
The formation of a thioester bond between ubiquitin and cysteine could be broken down by the redox agent beta-mercaptoethanol (BME). To further validate that polyubiquitylation takes place on Cys277, we pulled down ACAT2 with Ni-NTA beads in denaturing buffer and compared the level of ubiquitylation in the presence or absence of BME. As expected, we observed a downshift of the ubiquitylated ACAT2 to its original molecular weight in the presence of BME ( Fig. 2i ).
We next sought to determine the type of ubiquitin linkage on Cys277 of ACAT2. It is known that the carboxy terminus of ubiquitin can be covalently attached to the ε-amino groups of any of the seven lysine residues (Lys6-linked, Lys11-linked, Lys27-linked, Lys29-linked, Lys33-linked, Lys48-linked and Lys63-linked) or to the α-amino group of the N-terminal methionine (M1-linked) of ubiquitin. By using various ubiquitin mutants, we found that the mutant ubiquitin containing only a Lys48 was efficiently conjugated to ACAT2, and that arginine substitution of Lys48 (K48R) largely abrogated ACAT2 ubiquitylation ( Fig. 3a,b ).
We then analysed ACAT2 ubiquitylation using ubiquitin-linkagespecific antibodies. Different types of di-ubiquitin were subjected to western blotting with antibodies against linkage-specific ubiquitin including anti-M1, anti-Lys11, anti-Lys48, anti-Lys63 and P4D1 antibody (which detects all kinds of ubiquitin linkage), respectively. The results demonstrated that these antibodies are of high specificity ( Fig. 3c and Supplementary Fig. 3a ). The ubiquitin linkage on Cys277 was then studied with these confirmed antibodies. Although anti-M1, anti-K11 or anti-K63 gave no ubiquitylation signal on the ACAT2 proteins, anti-Lys48 ubiquitin antibody gave a dramatic signal for both ACAT2 (WT) and ACAT2 (K-null) in a sterol-regulated manner. In contrast, ACAT2 (C277A) was barely ubiquitylated. The corresponding type of di-ubiquitin peptides were loaded on the same gel ∼30 min later than the ACAT2 immunoprecipitation samples (due to the small molecular weight of di-ubiquitin) to serve as a positive control ( Fig. 3d and Supplementary Fig. 3b ).
Collectively, these data strongly support that Cys277 is the critical conjugation site for lipid-regulated ACAT2 ubiquitylation. Interestingly, this cysteine residue is highly conserved among ACAT2 proteins from different species, whereas in the ACAT1 protein it is an alanine that occupies the position ( Supplementary Fig. 2i ).
Lipid-induced ACAT2 stabilization is mediated by ROS via Cys277 oxidation
We next sought to address why lipid-regulated degradation of ACAT2 requires the ubiquitylation at a cysteine instead of a lysine. It is known that high levels of lipids cause oxidative stress and that cysteine is readily oxidized. We thus hypothesized that sterols and FAs may induce ROS to oxidize Cys277 and hence prevent ACAT2 ubiquitylation and subsequent degradation. As shown in Fig. 4 , cholesterol, sterol intermediates (7-DHC, lanosterol), oxysterols and saturated FAs substantially promoted the generation of ROS. However, unsaturated FAs and phytosterols (beta-sitosterol, stigmasterol) failed to elicit ROS. The scatter graph shows a strong correlation between ROS production and ACAT2 protein level ( Fig. 4c ). We further determined critical concentrations of cholesterol (5 µg ml −1 ), 25-HC (1 µg ml −1 ) and PA (100 µM) that elicit ROS production and elevate ACAT2 protein level ( Supplementary Fig. 4a -i). Sterols and FAs induced ROS production in a time-dependent manner as early as 8 h ( Supplementary Fig. 4j -r). The elevation of ACAT2 was detected from 12 h since protein may take some time to accumulate.
To assess whether ACAT2 stability is regulated by cellular redox, we treated cells with the pro-oxidants menadione or H 2 O 2 and found that both oxidative reagents markedly stabilized ACAT2 ( Fig. 4d and Supplementary Fig. 5a ). In addition, short interfering RNA (siRNA) depletion of glucose-6-phosphate dehydrogenase (G6PD), a key enzyme in synthesizing the main intracellular reductant NADPH, also resulted in ACAT2 stabilization ( Fig. 4e ), in agreement with the notion that G6PD deficiency sensitizes cells to oxidative stress. Furthermore, menadione or H 2 O 2 dramatically lessened ACAT2 ubiquitylation ( Fig. 4f and Supplementary Fig. 5b ), whereas the antioxidant N -acetyl-L-cysteine (NAC) attenuated lipid-induced stabilization of ACAT2 ( Fig. 4g ).
We next tested whether Cys277 of ACAT2 could be oxidized by ROS. Cysteine oxidation may result in the formation of sulfenic acid (-SOH), which can be detected by DCP-Bio1 ( Fig. 4h) [13] [14] [15] . Following 25-HC/PA treatment, ACAT2 was labelled by DCP-Bio1 in a timedependent manner ( Fig. 4i ). However, ACAT2 (C277A) was barely labelled by the probe (Fig. 4j ). It is thus concluded that sterols and FAs trigger ROS, which then oxidize Cys277 and impede ubiquitylationmediated degradation of ACAT2.
gp78-Insigs mediates the ubiquitylation and degradation of ACAT2
To identify the E3 of ACAT2, the ACAT2 complex was immunoprecipitated from the membrane fraction of CHO/ACAT2-Myc cells and subjected to tandem-mass-spectrometry analysis. gp78, a membraneanchored E3, was revealed. It has been reported that gp78 interacts with Insig1/2 and promotes sterol-regulated ubiquitylation of Supplementary Fig. 3a . (d) CHO cells were transfected with pCMV-HA-Ub together with the plasmid expressing Myc-tagged ACAT2 (WT), (K-null) or (C277A) and depleted of lipids for 16 h. Cells were treated with or without 25-HC for 11 h. Then MG132 was added into the medium for another 5 h. Cells were harvested and lysed. The ACAT2 proteins were immunoprecipitated by anti-Myc antibodies coupled to agarose beads and eluted with Myc peptides. Western blotting was carried out using different ubiquitin linkage antibodies or anti-Myc antibody as indicated. The di-ubiquitin was loaded about 30 min later than ACAT2 samples and served as a control. The independent repeat of these experiments is shown in Supplementary Fig. 3b . Unprocessed original scans of blots are shown in Supplementary Fig. 8 . 
The ubiquitylation on Cys277 of ACAT2 is regulated by oxidative stress. (a-c) CHO/ACAT2-Myc cells were depleted of lipids as depicted in Fig. 1a and treated with vehicle or different kinds of sterol and FA. Cells were harvested for western blotting and ROS measurement. (a) Blots were quantified and the mean intensity of ACAT2 normalized to β-actin is indicated (from three independent experiments, control treatment is defined as 1). (b) ROS levels are presented as mean ± s.d., n = 3 independent experiments. (c) A correlation (R 2 = 0.97, P < 0.0001) between lipidinduced ROS production and ACAT2 protein level was analysed by GraphPad Prism and is demonstrated by a scatter diagram. BSA, bovine serum albumin. (d) CHO/ACAT2-Myc cells were depleted of lipids and treated with 25-HC/PA or menadione (12.5 µM) as indicated. Sixteen hours later, cells were harvested for western blotting. (e) SV589 cells transfected with ACAT2 plasmid and the indicated siRNAs were depleted of lipids and treated with 25-HC or PA. Cells were harvested 16 h later for western blotting.
(f) CHO/ACAT2-Myc cells were depleted of lipids and treated with 25-HC/PA or menadione as indicated. Eleven hours later, cells were treated with MG132. After incubation for another 5 h, cells were harvested for ubiquitylation assay. (g) CHO/ACAT2-Myc cells were depleted of lipids, pretreated with NAC (7.5 mM) for 1 h and then incubated with vehicle or 25-HC/PA for 16 h. Then the cells were harvested for western blotting. (h) A scheme showing how the DCP-Bio1 probe detects the oxidation of Cys277 in ACAT2. (i) CHO/ACAT2-Myc cells were depleted of lipids and treated with 25-HC/PA for the indicated durations. Cells were then harvested for sulfenic acid detection as described in the Methods. (j) CHO cells transfected with plasmids expressing ACAT2 variants were depleted of lipids and treated with 25-HC/PA for 8 h. Cells were then harvested for sulfenic acid detection. The immunoblots are representative of three independent experiments. Unprocessed original scans of blots are shown in Supplementary Fig. 8 . Statistics source data for a-c can be found in Supplementary Table 2 . depleted of lipids and treated with 25-HC. Sixteen hours later, cells were harvested for western blotting. (g) SV589 cells were transfected with ACAT2 expression plasmid and siRNAs, depleted of lipids and treated with PA. Sixteen hours later, cells were harvested for western blotting.
(h) SV589 cells were transfected with ACAT2 expression plasmid and siRNAs, depleted of lipids and treated with 25-HC, PA, or both. Eleven hours later, cells were treated with MG132. After an additional 5 h, cells were harvested for ubiquitylation assay. (i) CHO cells were transfected with the indicated plasmids, depleted of lipids and treated with MG132 for 5 h. Cells were then harvested for co-immunoprecipitation analysis.
(j) SV589 cells were transfected with plasmids and siRNAs, depleted of lipids and treated with MG132 for 5 h. Cells were then harvested for co-immunoprecipitation analysis. The immunoblots are representative of three independent experiments. Unprocessed original scans of blots are shown in Supplementary Fig. 8 . Statistics source data for d can be found in Supplementary Table 2 .
HMG-CoA reductase (HMGCR), a rate-limiting enzyme in cholesterol biosynthesis 16 . We thus evaluated the role of gp78 and Insigs in ACAT2 degradation. Overexpression of WT gp78 remarkably promoted ACAT2 degradation. Conversely, the dominant-negative mutant gp78 increased the amount of ACAT2 ( Supplementary Fig. 5c ). Moreover, knockdown of gp78, but not Hrd1 (an independent ER membrane E3) or Sel1L (an ER protein involved in ER-associated degradation), dramatically increased the ACAT2 level ( Fig. 5a ). These data suggest that gp78 specifically mediates ACAT2 ubiquitylation and degradation. To confirm these in vitro results, we also measured the ACAT2 level in gp78 −/− CHO cells or primary hepatocytes from liverspecific gp78 −/− mice. ACAT2 was constitutively stable regardless of sterol treatment when gp78 was absent ( Fig. 5b,c) . Consistently, the ACAT2 level was significantly higher in the liver and intestine of gp78 −/− mice compared with that of WT littermates (Fig. 5d ).
Since Insig1/2 work as cofactors of gp78 in recruiting substrates, we asked whether Insigs were required for ACAT2 degradation. ACAT2 stabilization was detected in Insig1, Insig2 or Insig1/2 siRNA-depleted cells (Fig. 5e ), as well as in SRD15 cells (Fig. 5f ), a cell line deficient in both Insigs 17 . Moreover, knockdown of gp78 or Insigs abolished lipidregulated ACAT2 ubiquitylation and degradation (Fig. 5g,h) .
We next performed co-immunoprecipitation experiments to evaluate the interactions. We found that ACAT2 directly bound Insig1 but not gp78 ( Fig. 5i ). Knockdown of Insigs abolished ACAT2-gp78 association (Fig. 5j ). These results indicate that ACAT2, gp78 and Insigs form a triplex and that Insigs mediate ACAT2 and gp78 interaction. Importantly, ACAT2-Insig1 association was independent of Cys277 ( Supplementary Fig. 5d ) or of redox state ( Supplementary  Fig. 5e-g) , ruling out the possibility that oxidation may regulate ACAT2-Insig-gp78 interaction. In addition, gp78 was neither oxidatively modified nor inactivated by ROS ( Supplementary Fig. 6a,b ).
ACAT2 −/− mice are more susceptible to HFD-induced insulin resistance
To examine whether ACAT2 deletion results in FC and FFA overaccumulation in vivo, we fed WT and ACAT2 −/− mice with HFD or chow diet for 12 weeks. We observed an increase in FFA (14% and 24% higher in the plasma and liver respectively) and a decrease in CE content (15% and 96% lower in the plasma and liver respectively) in ACAT2 −/− mice fed on HFD compared with WT controls (Fig. 6a ). To confirm that ACAT2 converts saturated FAs to CEs, we measured hepatic CE composition of WT mice by liquid chromatography/mass spectrometry. The content of saturated FAs (16:0 and 18:0) was substantially higher in HFD-fed mice than chowdiet-fed mice ( Supplementary Fig. 7d ). These data suggest that ACAT2 prevents FFA over-accumulation by catalysing CE formation.
To investigate whether ACAT2 deletion exacerbates HFD-induced insulin resistance, we performed a glucose tolerance test (GTT) and an insulin tolerance test (ITT) and found that ACAT2 −/− mice were much less sensitive to insulin than WT littermates when fed on HFD. However, no differences were detected between WT and ACAT2 −/− mice fed on chow diet (Fig. 6b,c) . In addition, we injected insulin intraperitoneally and assayed the liver for AKT phosphorylation 10 min post-injection. Insulin-stimulated phosphorylation of AKT was much lower in ACAT2 −/− mice compared with WT mice on HFD ( Fig. 6d ,e, right panel). However, AKT phosphorylation was similar in both groups fed on chow diet ( Fig. 6d ,e, left panel). Together, these data indicate that ACAT2 −/− mice are more susceptible to HFD-induced insulin resistance than WT mice and that ACAT2 plays an important role in ameliorating lipotoxicity.
Stabilized ACAT2 protects from HFD-induced insulin resistance
To directly assess the effect of ACAT2 stabilization on metabolic parameters, we first asked whether Cys277 was required for enzyme activity. Microsomes were prepared from AC29 cells (ACAT-deficient CHO cells) stably expressing WT or C277A forms of ACAT2. The ACAT2 activity was measured in vitro. ACAT2 (C277A) demonstrated similar capability of catalysing CE formation to WT ACAT2 ( Fig. 7a-c) . These results suggest that Cys277 is dispensable for the enzyme activity, consistent with the previous finding that His434 (equivalent to His438 in the African green monkey) is the catalytic site of human ACAT2 (ref. 18) .
We next delivered adeno-associated virus (AAV)-expressing WT and C277A forms of ACAT2 to ACAT2 −/− mice. AAV2/8 is a hepatotropic serotype of AAV, and, as expected, ACAT2 was selectively expressed in the liver ( Supplementary Fig. 6c ). In addition, the mRNA level of exogenous ACAT2 was comparable to that of endogenous ACAT2 in WT mice ( Supplementary Fig. 6d ), suggesting that AAV2/8-mediated delivery mimics the knock-in situation of ACAT2. When fed on HFD for 12 weeks, ACAT2 (C277A)-expressing mice showed much lower FFA levels (14% and 18% lower in the plasma and liver respectively) and much higher CE content (12% and 16% higher in the plasma and liver respectively) than ACAT2 (WT)-expressing mice (Fig. 7d ). In addition, the CE contents of lipoproteins in ACAT2 (C277A)-expressing mice were higher as revealed by fast performance liquid chromatography analysis ( Supplementary Fig. 6e ).
GTT and ITT showed that HFD induced insulin resistance in both ACAT2 (WT)-and (C277A)-expressing mice. However, ACAT2 (C277A)-expressing mice displayed higher glucose clearance ability and insulin sensitivity than did ACAT2 (WT)-expressing mice (Fig. 7e,f) . Consistently, the insulin-induced phosphorylation level of AKT in ACAT2 (C277A) mice was higher than in ACAT2 (WT) mice when fed on HFD (Fig. 7g,h) . Together, these data further validated that the stabilization of ACAT2 ameliorates lipotoxicity by catalysing CE formation.
According to these findings, we proposed a model to illustrate the protective effects of ACAT2 on lipotoxicity and insulin resistance induced by lipids, as depicted in Supplementary Fig. 6f . When cellular lipid levels are low, the gp78-Insigs complex binds ACAT2 and catalyses the ubiquitylation of Cys277, thus promoting ACAT2 degradation. An elevation in cholesterol and FA levels triggers ROS production, which oxidizes Cys277 and prevents ACAT2 ubiquitylation. As a result, increased ACAT2 converts cholesterol and FA to CEs, thereby reducing lipotoxicity. The utilization of a cysteine as an unconventional ubiquitylation site represents a lipid-induced ROS sensing and protection mechanism.
DISCUSSION
The current study shows that ACAT2 is stabilized by cholesterol and FA. It is ubiquitylated on a cysteine rather than a lysine. Lipids including free cholesterol and saturated FAs induce ROS, which oxidize Cys277 of ACAT2 and protect the protein from degradation. The stabilized ACAT2 further converts cholesterol and FAs to CEs, thereby preventing the lipotoxicity of polar lipids.
gp78 is a membrane-anchored ubiquitin ligase with five transmembrane domains 19, 20 . It binds to Ufd1, VCP and UBE2G2 via the cytosolic domain, and associates with Insig1/2 through the transmembrane domain 16, [21] [22] [23] . Insigs work as adaptors to recruit substrates including ACAT2 and HMGCR 24 . Interestingly, although both ACAT2 and HMGCR are gp78 substrates, their ubiquitylation is regulated in opposite directions. When the cholesterol level rises, HMGCR binds gp78-Insigs and is targeted to degradation 16 . Meanwhile, a high level of cholesterol and FA induces the generation of ROS to oxidize Cys277 and prevent ACAT2 degradation. These two mech- Supplementary Table 2 . Unprocessed original scans of blots are shown in Supplementary Fig. 8 .
becomes stabilized. Also, the availability of Cys277 confers ACAT2 to be ubiquitylated by gp78-Insigs. As a result, the cellular cholesterol level elevates quickly. In sum, the gp78-Insigs E3 complex plays a central role in cellular cholesterol homeostasis through modulating de novo synthesis and esterification. The specific sterols and FAs capable of stabilizing ACAT2 have been determined. Cholesterol, sterol intermediates in the mevalonate pathway and oxysterols can increase ACAT2 ( Supplementary  Fig. 1a,b ). This sterol specificity is especially important because ACAT2 is required for intestinal cholesterol absorption when the dietary cholesterol level is high. The stabilization of ACAT2 by cholesterol, therefore, substantiates highly efficient cholesterol absorption. Interestingly, neither ergosterol nor plant sterols could stabilize ACAT2 (Fig. 1e ). This might be another mechanism governing the specificity of cholesterol absorption, in addition to selective cholesterol uptake by NPC1L1 (refs 28,29) and preferential plant sterol export by ABCG5/8 (refs 30,31). On the other hand, only saturated but not unsaturated FAs increase the stability of ACAT2 (Fig. 1f ). As saturated FAs function as strong activators of ROS and insulin resistance 32 , this specificity grants ACAT2 a protective role against saturated FAinduced lipotoxicity. Interestingly, oleoyl-CoA has been shown to be the predominant intracellular FA substrate for ACAT2 since the CE content dramatically reduces in the liver of SCD1 −/− mice 33 . However, results from an in vitro assay identify palmitoyl-CoA as the most preferred fatty acyl-CoA for ACAT2 (ref. 34). We found that the amount of saturated FAs in hepatic CEs, despite being relatively small (less than 0.5 µg per milligram of liver protein), is substantially increased in mice fed on HFD ( Supplementary Fig. 7d ), suggesting that the ROS contributed by saturated FA following HFD may be partially relieved by ACAT2-mediated CE synthesis. Together, these data suggest that ACAT2 stabilization may counteract ROS through multiple angles. We also looked up the single-nucleotide polymorphisms (SNPs) at ACAT2 (±20 kilobases) in the Chinese GWAS 35 and DIAGRAM Consortium databases 36,37 , but found no significant correlation between SNPs in this region and type 2 diabetes (P ≥ 0.07). Whether ACAT2 SNPs or mutation contributes to metabolic diseases in human population needs further investigation.
Lipid-induced ROS elevation is a common pathophysiological characteristic of metabolic diseases. Our study reveals that ACAT2 acts as a key ROS-responding protein sensing lipid overload and oxidative stress. These results suggest that pharmacologically increasing the stability of ACAT2 could be an effective strategy to treat type 2 diabetes.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper. Antibodies. Primary antibodies used for immunoblotting were as follows: mouse monoclonal anti-ubiquitin antibody P4D1 (SC-8017, Santa Cruz, 1:500); rabbit polyclonal antibodies against ubiquitin M1 (ABS175, 1:1,000), Lys11 (MABS107, 1:1,000) Lys48 (05-1307, 1:1,000) and Lys63 (05-1308, 1:1,000) linkages were from Millipore; mouse monoclonal anti-T7 (69522, Millipore, 1:500); mouse monoclonal anti-HA (clone 16B12) (901503, Biolegend, 1:500); mouse monoclonal anti-β-actin (clone AC-15) (A1978, Sigma, 1:3,000); mouse monoclonal anti-Myc (clone 9E10) (2 µg ml −1 ) was prepared from hybridomas (ATCC); rabbit polyclonal antibody against Hrd1 (SC-130889, Santa Cruz, 1:1,000); rabbit polyclonal antibody against Sel1L (SC-48081, Santa Cruz, 1:1,000); rabbit polyclonal antibody against phosphorylated AKT (Ser473) (no. 4060, Cell Signaling Technology, 1:1,000), rabbit polyclonal antibody against total AKT (no. 9272, Cell Signaling Technology, 1:1,000); rabbit polyclonal antibody against human ACAT1 (SC-130578, Santa Cruz, 1:1,000); rabbit polyclonal antibody against human ACAT2 (100027, Cayman, 1:1,000). Rabbit polyclonal antibodies against mouse ACAT1 (2 µg ml −1 ) and ACAT2 (2 µg ml −1 ) were generated in our laboratory 39 . Rabbit polyclonal antibody against gp78 (2 µg ml −1 ) was prepared as described before 21 HepG2, Huh7, Hepa1-6 and SV589 cells were maintained in medium A supplemented with 10% FBS; Caco2 cells were maintained in medium A supplemented with 20% FBS; CHO-7 and SRD15 cells were maintained in medium B supplemented with 5% FBS; primary hepatocytes were maintained in medium C supplemented with 5% FBS; AC29 (an ACAT -deficient CHO cell line, a generous gift from T. Y. Chang at Dartmouth Medical School, USA) cells were maintained in medium D supplemented with 10% FBS. CHO-7 cells stably expressing pCMV-6× Myc-ACAT2 were generated as previously described 40 and maintained in medium C supplemented with 5% FBS plus G418. All of the cell lines have been tested and they have no mycoplasma contamination. No cell lines used in this study were found in the database of commonly misidentified cell lines that is maintained by ICLAC and NCBI Biosample. The cell lines were not authenticated.
Primary hepatocyte culture. Primary hepatocytes were isolated from the livers of male C57/BL6 mice (8-week-old) using collagenase perfusion as described previously 41 . Six-well plates were pre-coated with 0.5 ml of 0.75 mg ml −1 collagen I solution (collagen gel, gelation: ≥1 h at 37 • C) for sandwich cultures. Hepatocytes were plated at a density of 1.5 × 10 6 cells per well in 2 ml medium C supplemented with 10% FBS and 100 nM dexamethasone. Four hours after seeding, cells on collagen gel were washed twice with ice-cold PBS, overlaid with a second layer of collagen I gel and incubated with the indicated medium supplemented with 100 nM dexamethasone. Cell viability, as measured by trypan blue exclusion, was always greater than 80%. After incubation for 16 h, cells were switched to the indicated medium for various experiments.
Transfection. Transfection was performed using Fugene HD (Promega) according to the manufacturer's instructions. Primary hepatocytes were transfected with the indicated plasmids using Effectene transfection reagent (Qiagen).
Generating gp78 knockout CHO-7 cells. CHO-7 cells deficient in gp78 were generated by TALEN technology. Briefly, a pair of TALEN constructs with puromycin resistance for gp78 knockout was prepared using the Talen construction kit from Sidansai following the manufacturer's instructions and transfected into CHO-7 cells using Fugene HD (Promega). Twelve hours later, 6 µg ml −1 puromycin was added and maintained for 4 days. Surviving clones were isolated and screened for gp78 depletion by western blotting.
Fatty acid treatment. Stock solutions of various fatty acids were prepared by mixing free fatty acids with fatty-acid-free BSA. After delipidation, cells were treated with fatty acids at the concentrations and time durations indicated.
Ubiquitylation assays in non-denaturing or denaturing conditions. For the ubiquitylation assay in non-denaturing conditions, cells were homogenized in IP buffer (1× PBS, 1% NP-40, 1% deoxycholate and 5 mM EDTA, 5 mM EGTA, 0.1 mM leupeptin) supplemented with protease inhibitors (10 µM MG132, 10 mM N -ethylmaleimide (NEM) and cocktail). Immunoprecipitation was carried out with the anti-Myc agarose beads as previously described 23 Co-immunoprecipitation. Cells were harvested and lysed in 0.6 ml of IP buffer (1× PBS, 1% digitonin, 5 mM EDTA, 5 mM EGTA and cocktail) followed by centrifugation at 12,000g for 10 min at 4 • C. Immunoprecipitation was carried out as described previously 16 .
RNA interference. Duplexes of siRNA were synthesized by Genepharma. The sequences of the siRNAs targeting gp78, Hrd1, Insig1, Insig2 and G6PD were described previously 16, 42 . The sequence of siRNA targeting Sel1L is 5 -GGATATTCA CCTTGCGAAA-3 . The siRNA against an irrelevant gene, vesicular stomatitis virus glycoprotein (VSV-G), is 5 -GGCUAUUCAAGCAGACGGUTT-3 and used as a negative control. Transfection of siRNA was carried out as previously described 24 .
Measurement of intracellular ROS levels.
The intracellular ROS level was determined using oxidation-sensitive DCFH-DA fluorescent dyes (Sigma). Cells were washed twice with PBS and labelled on culture plates with DCFH-DA for 30 min at 37 • C in serum-free medium. At the end of the incubation, culture plates were trypsinized, resuspended in PBS and analysed using a FACScan flow cytometer (λ ex = 488 nm and λ em 530 nm band-pass filter). The mean fluorescence intensity of 10,000 cells was measured in each sample and corrected for autofluorescence from unlabelled cells.
Detection of cysteine sulfenic acid by DCP-Bio1 probe.
Cysteine sulfenic acid detection by DCP-Bio1 was performed as previously described with slight modification 43, 44 . Briefly, treated cells were washed with PBS and homogenized in DCP-Bio1 working lysis buffer (1× PBS, 1% NP-40, 1% sodium deoxycholate, 5 mM EDTA, 5 mM EGTA, 1 mM phenylmethyl sulfonyl fluoride, 0.1 mM aprotinin, 0.1 mM leupeptin, 10 mM NEM, 10 mM iodoacetamide, 100 µM DTPA and 200 U ml −1 catalase). Lysates were centrifuged at 12,000g for 10 min. Supernatants were collected and incubated with 1 mM DCP-Bio1 probe (Millipore) for 2 h on ice. For affinity capture of the labelled proteins, unreacted DCP-Bio1 was removed using a dialysis device (Pierce). Dialysed samples were precleared with Sepharose CL-4B beads (Sigma), applied to plugged columns containing high-capacity streptavidin-agarose beads (Pierce) and incubated overnight at 4 • C. Beads were then subjected to a series of stringent washes (at least four column volumes and two washes each) using 1% SDS, 4 M urea, 1 M NaCl, 10 mM dithiothreitol, 100 µM ammonium bicarbonate and water. Beads were boiled for 10 min and then the samples were analysed by western blotting analysis.
AAV preparation. AAV2/8-ACAT2 (WT) and AAV2/8-ACAT2 (C277A) were prepared by Obio Technology. Viral titre was 1.06 × 10 13 vg ml −1 for AAV2/8-ACAT2 (WT) and 1.32 × 10 13 vg ml −1 for AAV2/8-ACAT2 (C277A).
Animals and treatments.
Male C57BL/6 mice (6-8 week) were obtained from SLAC. The ACAT2 −/− mice were purchased from Jackson Laboratory. The gp78 f /f and liverspecific gp78 knockout mouse was constructed as previously reported 45 . The gp78 −/− mice were generated by crossing gp78 f /f mice with EIIA-Cre mice. To ensure genetic homogeneity, the ACAT2 −/− and gp78 −/− mice were both backcrossed to C57BL/6 mice for at least 10 generations. Both types of mice were viable, fertile, normal in size and did not display any gross physical or behavioural abnormalities. Male C57BL/6 mice, ACAT2 −/− , gp78 −/− and liver-specific gp78 −/− mice of 8-12 weeks of age were used in all experiments. Mice were fed ad libitum with standard chow diet prior to study, maintained in a pathogen-free environment in single-ventilated cages, and kept on a 12-h light/dark schedule. All animals were used in accordance with the guidelines of the Institutional Animal Care and Use Committee of the Shanghai Institutes for Biological Sciences. Mice were treated as described in the figure legends.
Glucose tolerance and insulin tolerance test in mice.
Mice were fasted overnight (for GTT) or for 6 h (for ITT) in advance. Glucose (1 g kg −1 body weight) (for GTT) or insulin (0.75 U kg −1 body weight) (for ITT) was injected intraperitoneally into mice followed by blood sampling from the tail vein for glucose measurements. Tail blood glucose levels were measured at 0, 30, 60 and 120 min after challenge using the Onetouch Ultra blood glucose monitoring system (LifeScan).
Blood and liver chemistry. The livers were homogenized and supernatants were harvested for lipid extraction. The total triglyceride level in the plasma and liver (Triglyceride Assay Kit, KINGHAWK), free fatty acid (NEFA C Test Kit, Wako) and free cholesterol and cholesterol ester (CE) (Amplex Red Cholesterol Assay Kit, Invitrogen) were determined following the manufacturers' instructions.
Fast performance liquid chromatography. One hundred and twenty microlitres of pooled plasma from five mice per group was diluted in 300 µl of PBS. Total diluted serum was injected onto a Superose 6 10/300 GL column (GE Healthcare Bio-Sciences AB) and eluted at a constant flow rate of 0.2 ml min −1 PBS. Fractions of 300 µl were collected and assayed for CE content using the Amplex Red Cholesterol Assay Kit (Invitrogen).
Measurement of CE composition by liquid chromatography/mass spectrometry.
Solvents for sample preparation and mass spectrometry analysis were purchased from Burdick and Jackson. All other chemical reagents were from Sigma. The lipid internal standard was cholesterol nonadecanoate (CE 19:0). For preparation of cholesterol ester extracts from liver, each liver sample (20-30 mg) was weighed and homogenized in 500 µl of ice-cold PBS. After determining protein concentrations by BCA assay (Beyotime), CE (19:0) internal standard was added to each homogenate. Then the homogenate was extracted by hexane/IPA = 3:2 in a glass tube. After vortexing and centrifugation, the upper organic phase was collected, mixed with hexane and extracted again. All organic phase was dried under argon and reconstituted in hexane prior to injection 46 .
Normal-phase lipid chromatography was carried out using Agilent 1260 Quat pump VL and Accela 1250 pump. We performed normal-phase liquid chromatography separation using a 2 mm × 250 mm Beckman silica column. The sample was run at a flow rate of 200 µl min −1 in mobile C phase (0.5% IPA in hexane). Eluent from all normal-phase chromatographic methods was modified with 10 mM ammonium acetate (NH 4 OAc) in IPA introduced prior to the ion source at a flow rate of 40 µl min −1 . Fractions with retention times were 3 min. The mass spectrometry was performed on a TSQ Vantage triple quadrupole mass spectrometer (Thermo Fisher Scientific). The mass spectrometer was operated in positive ion, multiple reaction monitoring (MRM) mode. MRM pairs employed in the detection method used the ammoniated CE precursor mass and the cholesterol product fragment with m/z = 369. The cholesterol fragment is common to all CEs 47 . They are listed in Supplementary Table 1 . The FA compositions of chow diet or high-fat diet were measured by liquid chromatography/mass spectrometry as previously described 48, 49 .
ACAT enzyme activity assay. On day 0, AC29 cells stably expressing human ACAT2 (WT) or ACAT2 (C277A) were set up at 1.5 × 10 6 per 100-mm dish in medium D supplemented with 10% FBS. On day 1, cells were switched to medium D supplemented with 5% D-FCS, 1 µM lovastatin and 50 µM mevalonate. On day 2, cells were switched to medium D containing 5% D-FCS, 1 µM lovastatin, 50 µM mevalonate in the absence or presence of 15 µg ml −1 cholesterol/cyclodextrin and 100 µM PA. After 16 h, cells were harvested, washed with PBS twice and homogenized in ACAT homogenization buffer (0.25 M sucrose, 1 mM EDTA, 0.1 M K 2 HPO 4 , pH 7.4) supplemented with protease inhibitor mixture (Sigma) by ultrasound sonication. Lysates was centrifuged at 12,000g for 20 min at 4 • C. Supernatants were then centrifuged at 100,000g for 60 min at 4 • C and the microsomal pellet was resuspended in ACAT reaction buffer (0.1 M K 2 HPO 4 , pH 7.4) supplemented with protease inhibitor mixture (Sigma). The microsomal suspension was stored at −80 • C until use. The activity of acyl-CoA:cholesterol acyltransferase in the microsomes was determined by the rate of incorporation of (1-14 C) oleate into the cholesteryl ester fraction. This assay included 100 µg of microsomal protein, 0.1 M K 2 HPO 4 , pH 7.4, 50 nM cholesterol, 1 mg of fatty acid-free human serum albumin in a total volume of 290 µl. The esterification of cholesterol was initiated by adding 0.1 µCi of 1-14 C oleoyl-CoA (specific activity 5 Ci mol −1 , Amersham Biosciences) into the reaction system, making the final incubation volume 300 µl. After incubation for 10 min at 37 • C, the reaction was terminated by adding 6 ml of chloroformmethanol (2:1, v/v). One hour later, 1.2 ml of 0.88% KCl was added and the phases were allowed to separate overnight at room temperature. The upper aqueous phase in each tube was aspirated and the remaining organic phase was evaporated under liquid N 2 . Lipid was then resuspended in CHCl 3 containing 5 mg ml −1 cholesteryl oleate and applied to a silica gel-60 TLC plate. The separation of the lipids was done in hexane/ethyl ether/acetic acid (70:30:1) and bands on the TLC plate were visualized with I 2 vapour. CE bands were scraped and suspended in scintillation fluid for radioactivity measurement in a liquid scintillation spectrometer.
Western blot analysis. Cells were harvested and homogenized in 120 µl of RIPA buffer supplemented with protease inhibitors. The protein concentration of wholecell lysates was determined according to the Lowry method (Bio-Rad). Samples were mixed with 4× SDS loading buffer (150 mM Tris-HCl, pH 6.8, 12% SDS, 30% (v/v) glycerol, 0.02% (w/v) bromophenol blue, 6% (v/v) beta-mercaptoethanol) and boiled for 10 min. Proteins were resolved by SDS-PAGE and transferred onto PVDF membranes. Immunoblots were blocked with 5% BSA in TBS containing 0.075% Tween and probed with primary antibodies overnight at 4 • C. After washing in TBST 3 times, blots were incubated with secondary antibodies for 1 h at room temperature.
Ubiquitylation assay western blot. For Figs 2b,d ,g,h, 3a,b, 4f and 5h, and Supplementary Figs 5b and 6b , after the last wash of the beads, the supernatant was discarded and beads were boiled for 10 min in 100 µl 2× SDS loading buffer (75 mM Tris-HCl, pH 6.8, 6% SDS, 15% (v/v) glycerol, 0.01% (w/v) Bromophenol blue) and were then vortexed and centrifuged at 1,000g for 2 min. 90 µl supernatant was mixed with 90 µl solubilization buffer (62.5 mM Tris-HCl, pH 6.8, 15% SDS, 8 M Urea, 10% glycerol) and incubated at 37 • C for 30 min. For Fig. 3d and Supplementary  Fig. 3b , the beads were incubated with 100 µl Myc peptide (1 mg ml −1 ) for 3 h at 4 • C, vortexed and centrifuged at 1,000g for 2 min. 90 µl supernatant was mixed with 90 µl solubilization buffer (62.5 mM Tris-HCl, pH 6.8, 15% SDS, 8 M Urea, 10% glycerol) and 60 µl modified 4× SDS loading buffer (150 mM Tris-HCl, pH 6.8, 12% SDS, 30% (v/v) glycerol, 0.02% (w/v) Bromophenol blue) and incubated at 37 • C for 30 min. Samples were resolved by SDS-PAGE and transferred onto PVDF membranes. Immunoblots were blocked with 5% BSA in TBS containing 0.075% Tween (TBST) and probed with primary antibodies overnight at 4 • C. After washing in TBST 3 times, blots were incubated with secondary antibodies for 1 h at room temperature. After washing in TBST 3 times, bands were visualized by enhanced chemiluminescence (ECL).
RT-qPCR.
Total RNA was extracted using Trizol reagents (Invitrogen) and subjected to reverse transcription (RT) with oligo dT followed by qPCR using target-specific primers in the Stratagene Mx30005P Q-PCR Systems. All reactions were prepared in triplicate and the relative amounts of mRNAs were calculated using the comparative CT method. Human or mouse cyclophilin was used as a control. Values show the amount of mRNA relative to the control sample, which is arbitrarily defined as 1. Primer sequences used are as follows: mouse ACAT1: (forward: 5 -CCGAGACA ACTACCCAAGGA-3 , reverse: 5 -CACACACAGGACCAGGACAC-3 ); mouse ACAT2 (forward: 5 -ATGTTCTACCGGGACTGGTG-3 , reverse: 5 -CCCGAAAA CAAGGAATAGCA-3 ); human ACAT1: (forward: 5 -GATGAAGGAAGGCTGGT GC-3 , reverse: 5 -GGAAGCTGGTGGCAGTGTAT-3 ); human ACAT2: (forward: 5 -CATGCTGCTGCTCATCTTCT-3 , reverse: 5 -ACTGCGGAGACCAGGAACA -3 ); mouse cyclophilin: (forward: 5 -TGGAGAGCACCAAGACAGACA-3 , reverse: 5 -TGCCGGAGTCGACAATGAT-3 ); human cyclophilin: (forward: 5 -GTCTCCT TTGAGCTGTTTGC-3 , reverse: 5 -CTGGGAACCATTTGTGTTGG-3 ).
Statistical analyses and reproducibility. The between-group variances were similar, and the data were normally distributed. All statistical analyses were performed using DOI: 10.1038/ncb3551 the SPSS software (version 11.5). Data were expressed as means ± s.d. and analysed by unpaired two-tailed Student's t-test or two-way ANOVA as indicated. Statistical tests were justified as appropriate for every figure. Statistical significance was set at P < 0.05. Sample sizes, statistical tests and P values for each experiment are depicted in the relevant figure legends. Specific samples size was chosen on the basis of similar experiments of previous studies. No statistical method was used to predetermine sample size. All samples/animals were randomly allocated to experimental groups and processed and the investigators were blinded to the group allocation during the experiment and/or when assessing the outcome. All experiments were successfully repeated three times in the laboratory. Each immunoblot was representative of three independent experiments and unprocessed original scans of blots are shown in Supplementary Fig. 8 . Figs 1b,d, 4a-c, 5d , 6a-c,e and 7a-f,h and Supplementary Figs 1d, 4a-r, 6d ,e and 7a-f have been provided as Supplementary  Table 2 . All other data supporting the findings of this study are available from the corresponding author on reasonable request. depleted of lipids for 16 hrs. Cells were treated with or without 25-HC for 11 hrs. Then MG132 was added into medium for another 5 hrs. Cells were harvested and lysed. The ACAT2 proteins were immunoprecipitated by anti-Myc antibodies coupled agarose and eluted with Myc peptides.
Data availability. Source data for
Western blotting was carried out using different ubiquitin linkage antibodies or anti-Myc antibody as indicated. The di-ubiquitin was loaded about 30 min later than ACAT2 samples and served as controls. This is an independent repeat of the experiments in Fig. 3d . Uncropped blots are shown in Supplementary Fig. 8 . 0 1.1 1.1 2.2 4.5 7.1   1.0 1.1 1.1 4.4 Supplementary Figure 5 Analysis of the ubiquitination, degradation and protein binding of ACAT2 (a) CHO/ACAT2-Myc cells were depleted of lipids, treated with H 2 O 2 for indicated time durations and harvested for western blotting. (b) CHO/ACAT2-Myc cells were depleted of lipids for 27 hrs. Cells were then treated with H 2 O 2 for indicated times in the presence of 10 mM MG132 and harvested for ubiquitination assay. (c) CHO cells were transfected with plasmids expressing Myc-tagged ACAT2 and HA-tagged gp78 WT or its variants including C356S-RING finger domain mutation (RINGmut), or M467F, F468S, P469S-CUE domain mutation (CUEmut) as indicated. 48 hrs later, cells were harvested for western blotting. (d) CHO cells were transfected with plasmids expressing Myc-tagged ACAT2 (WT) or (C277A) and T7-tagged Insig1 and depleted of lipids for 27 hrs. Cells were then treated with MG132 for another 5 hrs. Cells were harvested and lysed in the non-denaturing IP buffer, and subsequently subjected to co-IP analysis. (e) CHO cells transfected with plasmids expressing Myc-tagged ACAT2, HA tagged-gp78 and T7-tagged-Insig1 were depleted of lipids and treated with 25-HC/PA or menadione as indicated. 11 hrs later, cells were treated with MG132. After incubation for another 5 hrs at 37 °C, cells were harvested, lysed in the absence (-) or presence (+) of 20 mM DTT, and subsequently subjected to co-IP analysis. (f) CHO cells transfected with plasmid expressing Myc-tagged ACAT2 (WT) or (C-null) were depleted of lipids and treated with vehicle or 25-HC/PA. Cells were harvested 16 hrs later for western blotting. (g) CHO cells transfected with plasmids expressing Myc-tagged ACAT2 (WT) or (C-null) in combination with HA tagged-gp78 and T7-tagged-Insig1 were depleted of lipids and treated with vehicle or menadione as indicated. 11 hrs later, cells were treated with MG132. After incubation for another 5 hrs, cells were harvested for co-IP analysis. The immunoblots are representative of 3 independent experiments. Uncropped blots are shown in Supplementary Fig. 8 . 
